MISTER-B: Community-based Approaches to Treating Hypertension and Colon Cancer Prevention

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT01092078
Collaborator
Cornell University (Other), Wayne State University (Other)
740
1
3
48
15.4

Study Details

Study Description

Brief Summary

Black men constitute the demographic group with the greatest burden of premature death and disability from hypertension (HTN) in the United States. But while the disproportionately high rate of hypertension-related morbidity and mortality is well documented, the epidemic of colorectal cancer (CRC) among black men is comparatively under-appreciated. For example, CRC is a leading cause of cancer death in black men with a death rate 50% higher than in white men. Low rates of screening for CRC in this population contribute significantly to this problem. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of a lifestyle intervention delivered through telephone-based motivational interviewing (MINT) versus a patient navigation intervention on blood pressure reduction and CRC screening.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MINT
  • Behavioral: Patient Navigation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
740 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
Study Start Date :
May 1, 2010
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Motivational Interviewing

Individuals in the motivational interviewing (MINT) arm of the study will receive telephone-based lifestyle interviewing for 6-months. Counseling will be aimed at modifying diet and/or physical activity behaviors associated with decreasing blood pressure.

Behavioral: MINT
Motivational interviewing for lifestyle changes associated with treating hypertension

Experimental: Patient Navigation

Participants in the patient navigation arm will receive patient navigation for colonoscopy.

Behavioral: Patient Navigation
Patient navigation for colonoscopy.

Experimental: PLUS

Both patient navigation for colorectal cancer screening and motivational interviewing for blood pressure control

Behavioral: MINT
Motivational interviewing for lifestyle changes associated with treating hypertension

Behavioral: Patient Navigation
Patient navigation for colonoscopy.

Outcome Measures

Primary Outcome Measures

  1. Blood Pressure [Outcome is measured at 6-month follow-up]

    Three blood pressure measures and the average of the three measures will be obtained at baseline and 6-month follow-up using a Welch Allyn Vital Signs automated blood pressure monitor.

  2. Colon Cancer Screening Behavior [The outcome will be measured at 6-month follow-up]

    Whether or not the participant was screened for colon cancer between baseline and 6-month follow-up will be assessed using self-report and patient medical records.

Secondary Outcome Measures

  1. Medication Adherence [6-month follow-up]

    Medication adherence will be assessed using the 4-item Morisky Medication Adherence scale.

  2. Physical Activity [6-month follow-up]

    Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ).

  3. Intrinsic Motivation to Exercise [6-month Follow-up]

    Intrinsic motivation will be assessed using a 17-item questionnaire.

  4. Self-Efficacy (Exercise) [6-month follow-up]

    Self-efficacy related to exercise will be measured using a 12-iten questionnaire.

  5. Dietary Intake [6-month follow-up]

    Dietary intake will be assessed using the Food Frequency Questionnaire.

  6. Intrinsic Motivation (Diet) [6-month follow-up]

    Intrinsic motivation relating to diet will be assessed using a 17-item scale.

  7. Self-efficacy (Diet) [6-month follow-up]

    Self-efficacy relating to diet will be assessed using a 10-item scale.

  8. Facilitators and Barriers to obtaining a colonoscopy [6-month follow-up]

    Facilitators and barriers to obtaining a colonoscopy will be assessed using a self-reported scale.

  9. Behavioral Intention relating to colon cancer screening [6-month follow-up]

    Behavioral intention to screen for colon cancer will be assessed using a self-reported scale.

  10. Social Influence relating to colon cancer screening [6-month follow-up]

    Social influence relating to colon cancer screening will be assessed using a self-reported questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Participants must be age 50 years or older,

  2. Self-identify as a black or African American male,

  3. Have uncontrolled hypertension as defined by systolic blood pressure (SBP) > 135 mmHg or diastolic blood pressure (DBP) > 85 mmHg and SBP > 130 or DBP > 80 mmHg (in those with diabetes at the screening).

Exclusion Criteria:
  1. Inability to comply with the study protocol (either self-selected or by indicating during screening that he could not complete all requested tasks).

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU School of Medicine New York New York United States 10010

Sponsors and Collaborators

  • NYU Langone Health
  • Cornell University
  • Wayne State University

Investigators

  • Principal Investigator: Joseph Ravenell, MD, MS, NYU School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joseph E. Ravenell, MD, MS, Assistant Professor, NYU Langone Health
ClinicalTrials.gov Identifier:
NCT01092078
Other Study ID Numbers:
  • 09-0151
First Posted:
Mar 24, 2010
Last Update Posted:
Apr 22, 2015
Last Verified:
Apr 1, 2015
Keywords provided by Joseph E. Ravenell, MD, MS, Assistant Professor, NYU Langone Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2015